Go to deals
Healthcare | Private Equity

Senectovia Medizinaltechnik AG has been acquired by a financial investor

In the context of succession in the ownership, a multi-family office has taken over Senectovia Medizinaltechnik AG. The owner of Senectovia has sold 100% of the shares and the two parties have agreed not to disclose the sale price.

Senectovia Medizinaltechnik AG is specialized in the distribution and maintenance of products for decubitus prophylaxis and therapy, patient mobility and obesity care. The product range includes medical mattresses and aids for patient positioning and mobilization. Thanks to the excellent service and high quality of its products, Senectovia has become the market leader in its core business in German-speaking Switzerland.

The buyer is a multi-family office that prefers to invest in mid-sized companies in healthcare and other industries. With this investor, Senectovia has gained a strong partner who will actively promote and further develop the company’s strategy and growth plans.

The previous owner, who has played a key role in shaping the company for over 20 years, will remain closely associated with Senectovia as a member of the Board of Directors, and will contribute his extensive industry experience to the management committee in order to provide the new investor with optimum support in implementing the initiated strategy.

Oaklins’ team in Switzerland supported the owner of Senectovia Medizinaltechnik AG during the entire sale process as exclusive M&A advisors. This included the preparation of the sale documents, the identification and approach of potential buyers, the supervision of the buy-side due diligence, as well as negotiations with several parties and support up to the signing and closing of the transaction.

Parties
“With Oaklins, I had the optimal M&A advisor on my side, who accompanied me during a very challenging time for our company and implemented a succession process tailored to my needs. I would particularly like to highlight Oaklins' professionalism, industry knowledge and ability to ensure that always multiple options for action were kept open for me until closing. At all times in the process, Oaklins acted with foresight, anticipating potential stumbling blocks and preparing me in the best possible way for each step of the process.”

Michael Lienhart

Owner, Senectovia Medizinaltechnik AG

Talk to the deal team

David Zürrer

Partner
Basel, Switzerland
Oaklins Switzerland

Dr. Roberto Tracia

Partner
Bern, Switzerland
Oaklins Switzerland

Related deals

St. Claraspital AG has been acquired by University Hospital Basel
Healthcare

St. Claraspital AG has been acquired by University Hospital Basel

University Hospital Basel (USB) has acquired St. Claraspital AG, expanding its network of specialized care and integrated services. With St. Claraspital’s strong community presence, expertise in acute and rehabilitation medicine and established outpatient clinics, this merger enhances USB’s ability to provide seamless, patient-centered treatment across the continuum of care. The completion of the transaction is subject to clearance by the Swiss Competition Commission (COMCO).

Learn more
Crux Agribotics has been acquired by VDL
Private Equity | Agriculture | Industrial Machinery & Components

Crux Agribotics has been acquired by VDL

Crux Agribotics, a Dutch AgTech innovator with a 40-year heritage in computer vision, robotics, software development and high-tech engineering, has been acquired by VDL Groep, an international industrial family business. Through the acquisition of Crux Agribotics, VDL Groep further strengthens its position in foodtech, one of the growth markets for this family-owned industrial company.

Learn more
Roxy Nails has sold a minority stake to Cap Invest and Premius Capital
Private Equity | Consumer & Retail

Roxy Nails has sold a minority stake to Cap Invest and Premius Capital

Roxy Nails has sold a minority stake to Cap Invest and Premius Capital, enabling the brand to accelerate growth, expand internationally and strengthen its capabilities by structuring teams and hiring new talent.

Learn more